EQUITY	12 Months Ended
Dec. 31, 2025
Equity [Abstract]
EQUITY	8. EQUITY Issuance of Common Stock In June 2024, the Company entered into securities purchase agreement providing for the issuance and sale by the Company of 3,703,704 shares of the Company’s common stock (the “June 2024 Shares”) at a price of $0.27 per share. The aggregate proceeds from the sale of the June 2024 Shares were approximately $1,000,000. In January 2025, the Company entered into a securities purchase agreement providing for the issuance and sale by the Company of 3,333,333 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds from these shares were approximately $500,000. In September 2025, the Company entered into securities purchase agreements providing for the issuance and sale by the Company of 3,666,667 shares of the Company’s common stock at a price of $0.15 per share. The aggregate proceeds from the sale of these shares were approximately $550,000.

The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/718/tableOfContent

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Name:	us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration